126 related articles for article (PubMed ID: 2658539)
21. Comparative study of low-dose oral granisetron plus dexamethasone and high-dose metoclopramide plus dexamethasone in prevention of nausea and vomiting induced by CHOP-therapy in young patients with non-Hodgkin's lymphoma.
Numbenjapon T; Sriswasdi C; Mongkonsritragoon W; Leelasiri A; Prayoonwiwat W
J Med Assoc Thai; 2002 Nov; 85(11):1156-63. PubMed ID: 12546311
[TBL] [Abstract][Full Text] [Related]
22. Protection from nausea and vomiting in cisplatin-treated patients: high-dose metoclopramide combined with methylprednisolone versus metoclopramide combined with dexamethasone and diphenhydramine: a study of the Italian Oncology Group for Clinical Research.
Roila F; Tonato M; Basurto C; Picciafuoco M; Bracarda S; Donati D; Malacarne P; Monici L; Di Costanzo F; Patoia L
J Clin Oncol; 1989 Nov; 7(11):1693-700. PubMed ID: 2681556
[TBL] [Abstract][Full Text] [Related]
23. Effective control of chemotherapy-induced nausea and vomiting with oral prednisone and metoclopramide.
Senn HJ; Glaus A; Bachmann-Mettler I
J Clin Oncol; 1984 Apr; 2(4):320-2. PubMed ID: 6538593
[TBL] [Abstract][Full Text] [Related]
24. Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy. A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepam.
González Barón M; Chacón JI; García Girón C; Ordóñez Gallego A; García de Paredes ML; Feliu J; Zamora P; Herranz C; Garrido P; Artal A
Acta Oncol; 1991; 30(5):623-7. PubMed ID: 1892680
[TBL] [Abstract][Full Text] [Related]
25. Difference in persistence of efficacy of two antiemetic regimens on acute emesis during cisplatin chemotherapy. The Italian Group for Antiemetic Research.
J Clin Oncol; 1993 Dec; 11(12):2396-404. PubMed ID: 8246029
[TBL] [Abstract][Full Text] [Related]
26. Antiemetic efficacy of droperidol or metoclopramide combined with dexamethasone and diphenhydramine. Randomized open parallel study.
Aapro MS; Froidevaux P; Roth A; Alberto P
Oncology; 1991; 48(2):116-20. PubMed ID: 1997933
[TBL] [Abstract][Full Text] [Related]
27. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
[TBL] [Abstract][Full Text] [Related]
28. A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trials Group Phase III Trial.
Warr D; Wilan A; Venner P; Pater J; Kaizer L; Laberge F; Latreille J; Stewart D; O'Connell G; Osoba D
Eur J Cancer; 1992; 29A(1):33-6. PubMed ID: 1332737
[TBL] [Abstract][Full Text] [Related]
29. Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis. The Italian Group for Antiemetic Research.
J Clin Oncol; 1997 Jan; 15(1):124-30. PubMed ID: 8996133
[TBL] [Abstract][Full Text] [Related]
30. High-dose oral and intravenous metoclopramide in doxorubicin/cyclophosphamide-induced emesis. A randomized double-blind study.
Edge SB; Funkhouser WK; Berman A; Seipp C; Tanner A; Wesley R; Rosenberg SA; Chang AE
Am J Clin Oncol; 1987 Jun; 10(3):257-63. PubMed ID: 3296734
[TBL] [Abstract][Full Text] [Related]
31. Antiemetic effect of oral versus intravenous metoclopramide in patients receiving cisplatin: a randomized, double-blind trial.
Anthony LB; Krozely MG; Woodward NJ; Hainsworth JD; Hande KR; Brenner DE; Greco FA; Burish TG
J Clin Oncol; 1986 Jan; 4(1):98-103. PubMed ID: 3510285
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the efficacy of tropisetron versus a metoclopramide cocktail based on the intensity of cisplatin-induced emesis.
Chang TC; Hsieh F; Lai CH; Tseng CJ; Cheng HH; Li CL; Michael BJ; Soong YK
Cancer Chemother Pharmacol; 1996; 37(3):279-85. PubMed ID: 8529290
[TBL] [Abstract][Full Text] [Related]
33. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S
J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536
[TBL] [Abstract][Full Text] [Related]
34. A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.
Bonneterre J; Chevallier B; Metz R; Fargeot P; Pujade-Lauraine E; Spielmann M; Tubiana-Hulin M; Paes D; Bons J
J Clin Oncol; 1990 Jun; 8(6):1063-9. PubMed ID: 2140854
[TBL] [Abstract][Full Text] [Related]
35. Comparison of antiemetic activity of chloropromazine and high doses of metoclopramide in cisplatin-based chemotherapy.
Tsavaris NB; Papaioannou D; Beldecos D; Kakoliris S; Mylonakis N; Karvounis N; Komitsopoulou P; Karagiaouris P; Sarmas J; Tzannou I
Acta Oncol; 1990; 29(8):1005-9. PubMed ID: 2278720
[TBL] [Abstract][Full Text] [Related]
36. Diphenhydramine for nausea and vomiting related to cancer chemotherapy with cisplatin.
Tsavaris N; Zamanis N; Zinelis A; Tsoutsos E; Mylonakis N; Bacoyannis C; Valilis P; Sarafidou M; Kosmidis P
J Pain Symptom Manage; 1991 Nov; 6(8):461-5. PubMed ID: 1955741
[TBL] [Abstract][Full Text] [Related]
37. A randomized trial of high dose bolus metoclopramide versus low-dose continuous infusion metoclopramide in the prevention of cisplatin-induced emesis.
Dana BW; McDermott M; Everts E; Abdulhay G
Am J Clin Oncol; 1987 Jun; 10(3):253-6. PubMed ID: 3296733
[TBL] [Abstract][Full Text] [Related]
38. [Prevention of nausea and emesis during cytostatic therapy. Antiemetic efficacy of high-dosage oral metoclopramide without and with prednisone].
Senn HJ; Köhler M; Glaus A; Bachmann-Mettler I; Weigand W
Dtsch Med Wochenschr; 1986 Jan; 111(4):129-35. PubMed ID: 3510848
[TBL] [Abstract][Full Text] [Related]
39. Antiemetic activity of two different high doses and schedules of metoclopramide in dacarbazine-treated cancer patients.
Roila F; Bracarda S; Basurto C; Sassi M; Lupattelli M; Picciafuoco M; Boschetti E; Del Favero A; Tonato M
Am J Clin Oncol; 1992 Apr; 15(2):112-4. PubMed ID: 1553897
[TBL] [Abstract][Full Text] [Related]
40. Antiemetic efficacy of high-dose intravenous metoclopramide and dexamethasone in patients receiving cisplatin-based chemotherapy: a randomized controlled trial.
Shinkai T; Saijo N; Eguchi K; Sasaki Y; Tamura T; Tominaga K; Sakurai M; Sano T; Taito H; Takahashi H
Jpn J Clin Oncol; 1986 Sep; 16(3):279-87. PubMed ID: 3534348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]